COMPASS Pathways plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMPS research report →
Companycompasspathways.com
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
- CEO
- Kabir Kumar Nath
- IPO
- 2020
- Employees
- 166
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $1.03B
- P/E
- -6.58
- P/S
- 0.00
- P/B
- 3.60
- EV/EBITDA
- -1.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -151.02%
- ROIC
- -44.02%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-287,862,000 · -85.57%
- EPS
- $-3.08 · -33.91%
- Op Income
- $-179,037,000
- FCF YoY
- -31.93%
Performance & Tape
- 52W High
- $11.65
- 52W Low
- $2.25
- 50D MA
- $7.49
- 200D MA
- $6.39
- Beta
- 2.40
- Avg Volume
- 3.88M
Get TickerSpark's AI analysis on CMPS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 26, 26 | Nath Kabir | other | 367,815 |
| Mar 26, 26 | Nath Kabir | other | 175,000 |
| Mar 26, 26 | Goodwin Guy | other | 115,600 |
| Mar 26, 26 | Goodwin Guy | other | 55,000 |
| Mar 26, 26 | Loxam Teri | other | 157,635 |
| Mar 26, 26 | Loxam Teri | other | 75,000 |
| Mar 11, 26 | Nath Kabir | other | 13,131 |
| Mar 11, 26 | Loxam Teri | other | 1,781 |
| Mar 2, 26 | Loxam Teri | other | 4,467 |
| Feb 2, 26 | Nath Kabir | other | 16,181 |
Our CMPS Coverage
View all →Want a deeper read on CMPS?
Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.
